227 related articles for article (PubMed ID: 19959513)
1. MR spectroscopy of the liver: principles and clinical applications.
Qayyum A
Radiographics; 2009 Oct; 29(6):1653-64. PubMed ID: 19959513
[TBL] [Abstract][Full Text] [Related]
2. Review of magnetic resonance spectroscopy in the liver and the pancreas.
Perman WH; Balci NC; Akduman I
Top Magn Reson Imaging; 2009 Apr; 20(2):89-97. PubMed ID: 20010063
[TBL] [Abstract][Full Text] [Related]
3. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review.
Fischbach F; Bruhn H
Liver Int; 2008 Mar; 28(3):297-307. PubMed ID: 18290772
[TBL] [Abstract][Full Text] [Related]
4. A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).
Tiwari P; Rosen M; Madabhushi A
Med Phys; 2009 Sep; 36(9):3927-39. PubMed ID: 19810465
[TBL] [Abstract][Full Text] [Related]
5. FID modulus: a simple and efficient technique to phase and align MR spectra.
Le Fur Y; Cozzone PJ
MAGMA; 2014 Apr; 27(2):131-48. PubMed ID: 23794131
[TBL] [Abstract][Full Text] [Related]
6. Non-water-suppressed proton MR spectroscopy improves spectral quality in the human spinal cord.
Hock A; MacMillan EL; Fuchs A; Kreis R; Boesiger P; Kollias SS; Henning A
Magn Reson Med; 2013 May; 69(5):1253-60. PubMed ID: 22745036
[TBL] [Abstract][Full Text] [Related]
7. Preliminary observations and diagnostic value of lipid peak in ovarian thecomas/fibrothecomas using in vivo proton MR spectroscopy at 3T.
Takeuchi M; Matsuzaki K; Harada M
J Magn Reson Imaging; 2012 Oct; 36(4):907-11. PubMed ID: 22585396
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
9. Prospective motion correction for single-voxel 1H MR spectroscopy.
Keating B; Deng W; Roddey JC; White N; Dale A; Stenger VA; Ernst T
Magn Reson Med; 2010 Sep; 64(3):672-9. PubMed ID: 20806374
[TBL] [Abstract][Full Text] [Related]
10. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
[TBL] [Abstract][Full Text] [Related]
11. Liver metabolite concentrations measured with 1H MR spectroscopy.
Ouwerkerk R; Pettigrew RI; Gharib AM
Radiology; 2012 Nov; 265(2):565-75. PubMed ID: 22891360
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
[TBL] [Abstract][Full Text] [Related]
13. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive MR thermography using the water proton chemical shift.
Kuroda K
Int J Hyperthermia; 2005 Sep; 21(6):547-60. PubMed ID: 16147439
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging.
Maudsley AA; Darkazanli A; Alger JR; Hall LO; Schuff N; Studholme C; Yu Y; Ebel A; Frew A; Goldgof D; Gu Y; Pagare R; Rousseau F; Sivasankaran K; Soher BJ; Weber P; Young K; Zhu X
NMR Biomed; 2006 Jun; 19(4):492-503. PubMed ID: 16763967
[TBL] [Abstract][Full Text] [Related]
16. Quantitative multivoxel proton chemical shift imaging of the breast.
Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
[TBL] [Abstract][Full Text] [Related]
17. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
18. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
19. Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model.
Yin X; Guo Y; Li W; Huo E; Zhang Z; Nicolai J; Kleps RA; Hernando D; Katsaggelos AK; Omary RA; Larson AC
Radiology; 2012 Jun; 263(3):714-22. PubMed ID: 22623693
[TBL] [Abstract][Full Text] [Related]
20. A novel phase and frequency navigator for proton magnetic resonance spectroscopy using water-suppression cycling.
Ernst T; Li J
Magn Reson Med; 2011 Jan; 65(1):13-7. PubMed ID: 20872862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
